Specifically, findings indicate that increased hip and waist circumference elevates the risk of myoclonic epilepsy, while a high body mass index (BMI) is associated with childhood absence epilepsy
Source: #EliLilly #Orforglipron #GLP1 #WeightManagement #ObesityTherapy #ClinicalTrials #Innovation SPER Market ResearchViginovix To view or add a comment, sign in Salubris' Innovative Small-Molecule Drug SAL0139 Approved for Clinical Trial in Hyperlipidemia Treatment Recently, Salubris received the Clinical Trial Approval Notice issued by the National Medical Products Administration (NMPA), granting approval for the companys independently developed innovative small-molecule drug, SAL0139 tablets (project code: SAL0139), to conduct clinical trials for the treatment of hyperlipidemia [1]
PIONEER REAL Netherlands was initiated in November 2020 and completed in December 2022, and was impacted by the coronavirus disease 2019 (COVID-19) pandemic (Fig
Check the column that fits your situation: Safe to stay on schedule No nausea, vomiting or reflux Not planning pregnancy within 8 weeks No surgery or endoscopy in the next 7 days Blood sugars well-controlled Consider holding or tapering Persistent vomiting or severe reflux Surgery or colonoscopy scheduled within 7 days Trying to conceive in the next 2 months (semaglutide) Severe side effects despite dose reductions Can You Speed Up Clearance
S.HarderJ
Until we address the underlying dysregulation, the noise will always exist in some form
